The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human expo...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
NTS-EXPOSURE
The innovative wastewater based epidemiology approach with t...
248K€
Cerrado
APOLLO
Assessing population health from exposure to tobacco specifi...
161K€
Cerrado
ECNIS2
ECNIS2 towards ECNIS Centre for Research and Education on C...
1M€
Cerrado
A-TEAM
ADVANCED TOOLS FOR EXPOSURE ASSESSMENT AND BIOMONITORING
4M€
Cerrado
AQUABIOTOX
Bioanalytical evaluation identification and characterisati...
261K€
Cerrado
Información proyecto HBM4EU
Duración del proyecto: 66 meses
Fecha Inicio: 2016-12-09
Fecha Fin: 2022-06-30
Líder del proyecto
UMWELTBUNDESAMT
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
75M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies and the evaluation of existing measures.
Key objectives include:
• Harmonizing procedures for human biomonitoring across 26 countries, to provide policy makers with comparable data on human internal exposure to chemicals and mixtures of chemicals at EU level;
• Linking data on internal exposure to chemicals to aggregate external exposure and identifying exposure pathways and upstream sources. Information on exposure pathways is critical to the design of targeted policy measures to reduce exposure;
• Generating scientific evidence on the causal links between human exposure to chemicals and negative health outcomes; and
• Adapting chemical risk assessment methodologies to use human biomonitoring data and account for the contribution of multiple external exposure pathways to the total chemical body burden.
We will achieve these objectives by harmonizing human biomonitoring initiatives in 26 countries, drawing on existing expertise and building new capacities. By establishing National Hubs in each country to coordinate activities, we will create a robust Human Biomonitoring Platform at European level.
This initiative contributes directly to the improvement of health and well-being for all age groups, by investigating how exposure to chemicals affects the health of different groups, such as children, pregnant women, foetuses and workers. We will also investigate how factor such as behavior, lifestyle and socio-economic status influence internal exposure to chemicals across the EU population. This knowledge will support policy action to reduce chemical exposure and protect health.